10 Biotech Stocks with Biggest Upside
In this article, we discuss 12 biotech stocks with biggest upside.
Harmony Biosciences Holdings Inc. (HRMY)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Vivo Capital Albert Cha And Frank Kung | 2,606,247 | $91,713,832 | 6.33% | |
| 2. | Adage Capital Management Phill Gross And Robert Atchinson | 1,200,000 | $42,228,000 | -16% | 0.09% |
| 3. | Perceptive Advisors Joseph Edelman | 891,370 | $31,367,310 | +792% | 0.9% |
| 4. | Citadel Investment Group Ken Griffin | 800,860 | $28,182,263 | +51% | 0% |
| 5. | Millennium Management Israel Englander | 488,400 | $17,186,796 | +11% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $24.00 | 339,476 | Large Shareholder | 10,651,120 | 2020-08-21 | Filing | |
| $34.30 | 3,922 | Director | 42,702 | 2020-08-26 | Filing | |
| $34.20 | 823 | Director | 38,780 | 2020-08-25 | Filing | |
| $24.00 | 132,503 | Large Shareholder | 4,409,803 | 2020-08-21 | Filing | |
| $34.30 | 3,057 | Director | 37,957 | 2020-08-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $59.96 | 2,834 | 2,571,024 | 2022-12-14 | Filing | ||
| $60.00 | 130 | Director | 2,147,943 | 2022-12-14 | Filing | |
| $60.13 | 6,320 | Director | 2,148,073 | 2022-12-13 | Filing | |
| $60.36 | 22,391 | Director | 2,154,393 | 2022-12-12 | Filing | |
| $59.89 | 9,847 | 2,573,858 | 2022-12-09 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 11,218,033 | $394,762,581 | 98.28% | |
| 2. | 5,750,478 | $202,359,321 | 0% | |
| 3. | 5,470,247 | $192,497,996 | 0.01% | |
| 4. | 3,595,857 | $126,538,208 | 0% | |
| 5. | 1,140,934 | $40,149,467 | 0% |
News See All
11 Most Undervalued Biotech Stocks to Buy According to Analysts
In this article, we will take a look at the 11 most undervalued biotech stocks to buy according to analysts.
5 Worst Performing Biotech Stocks in 2023
Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) develops treatments for neurological diseases such as schizophrenia. Cerevel Therapeutics Holdings, Inc.
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q2 2023 Earnings Call Transcript
Operator: Good morning. My name is Todd, and I will be your conference operator today.
15 Worst Performing NASDAQ Stocks In 2023
In this article, we discuss 15 worst performing NASDAQ stocks in 2023.
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q1 2023 Earnings Call Transcript
Operator: Good morning everyone. My name is Shelby and I will be your conference operator today.
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q4 2022 Earnings Call Transcript
Operator: Good morning everyone. My name is Todd and I will be your conference operator today.
13 High Growth Pharma Stocks that are Profitable
One industry that has rapidly evolved with time and impacted millions, if not billions, of lives is the pharmaceutical sector.
12 Cheap Biotech Stocks To Buy
Some of the more famous names in the biotech space include companies like Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), BioNTech SE (NASDAQ:BNTX), and AbbVie Inc. (NYSE:ABBV).
5 Best Healthcare Stocks For the Long Term
AbCellera Biologics Inc. (NASDAQ:ABCL) is a Canadian biotech company. AbCellera Biologics Inc. (NASDAQ:ABCL) is operating in the human antibodies space. Earlier in December AbCellera Biologics Inc.
Billionaire Hedge Funds
